Gloucester, MA, United States of America

Mehul Ganatra

USPTO Granted Patents = 7 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2010-2024

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Mehul Ganatra: Innovator in RNA Vaccine Technology

Introduction

Mehul Ganatra is a prominent inventor based in Gloucester, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of RNA vaccines. With a total of 7 patents to his name, Ganatra's work is paving the way for advancements in vaccine technology.

Latest Patents

One of his latest patents is focused on FCE mRNA capping enzyme compositions, methods, and kits. This patent relates to the creation of RNA vaccines that possess an appropriate cap structure. The systems, apparatus, compositions, and methods may utilize non-naturally occurring single-chain RNA capping enzymes. In some embodiments, the RNA capping enzyme may include an FCE variant that has an amino acid sequence at least 90% identical to specific positions of SEQ ID NO: 1, along with potential substitutions at designated positions.

Career Highlights

Mehul Ganatra is currently employed at New England Biolabs, Inc., where he continues to innovate in the field of molecular biology. His expertise in RNA technology has positioned him as a key player in the development of new therapeutic solutions.

Collaborations

Ganatra has collaborated with notable colleagues, including Christopher H. Taron and Siu-Hong Chan. These partnerships have further enhanced his research and development efforts in the biotechnology sector.

Conclusion

Mehul Ganatra's contributions to RNA vaccine technology exemplify the impact of innovative thinking in the field of biotechnology. His patents and ongoing work at New England Biolabs, Inc. highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…